Finally, SDC1 was enriched in bladder cancer, neuroactive ligand-receptor interaction, nod-like receptor signaling pathway, olfactory transduction, pathogenic Escherichia coli infection, and sphingolipid metabolism. This evidence concerns the gene SDC1 and urinary bladder carcinoma.